Combined Treatment of Platelet-rich Plasma (PRP) and Low-intensity Extracorporeal Shockwave Therapy (Li-ESWT) on Erectile Dysfunction (ED)
Combined Treatment of Platelet-rich Plasma (PRP) and Low-intensity Extracorporeal Shockwave Therapy (Li-ESWT) on Erectile Dysfunction (ED)
The purpose of this clinical study is mainly to use platelet-rich plasma combined with
 low-intensity extracorporeal shockwave therapy to treat patients with erectile dysfunction
 and observe the improvement results.
According to statistics from the Taiwan Society of Andrology, 18 to 25 years old male
 population in Taiwan having erectile dysfunction (ED) trouble is as high as 5 to 10 percent.
 At the same time, statistics from the Taiwan Sexual Dysfunction Counseling Training Committee
 show that as many as 50 percent of men between 40 and 70 years old have erectile dysfunction.
 Erectile dysfunction is the most common sexual dysfunction in men and is believed to be
 related to nerve or blood vessel damage, and often significantly affects the patients'
 quality of life.

 PRP is the abbreviation of "platelet-rich plasma". It can release growth factors and
 cytokines in the body to further promote tissue repair. The results of pre-clinical and
 clinical trials show that PRP can promote the repair of cavernous tissue, protect erection
 function of nerve, and stimulate the regeneration of nerve.

 Low-intensity extracorporeal shockwave therapy (Li-ESWT) is a non-invasive treatment. Under
 this treatment, it will help body producing angiogenesis-related proteins, stimulating the
 formation of small blood vessels, generating new blood vessels at the site to be treated, and
 increasing the perfusion flow of local tissues. Li-ESWT has been clinically shown to have a
 significant effect on erectile dysfunction.

 The purpose of this clinical study is mainly to use platelet-rich plasma combined with
 low-intensity extracorporeal shockwave therapy to treat patients with erectile dysfunction
 and observe the improvement results.
Inclusion Criteria:

 -  Impotence for more than three months

 -  International index of erectile function, (IIEF) less than 21( including 21)

 -  Erectile hardness score, (EHS) less than 3( including 3)

 -  Age over 30 years old

 Exclusion Criteria:

 -  Hypogonadism

 -  Bleeding tendency

 -  Could not cooperate with the treatment

 -  AIDS, syphilis and condyloma victim

 -  Received radical prostatectomy

 -  Prostate cancer or pelvis malignant tumor victim

 -  Gonad dysfunction

 -  Penis deformities

 -  Penile prosthesis implantation

 -  Psychiatric disease victim

 -  Neural disease ( multiple myeloma , brain atrophy, etc)

 -  Pacemaker implantation

 -  Not suitable join this trial judged by Investigator

 -  Alcohol or drug abuse